Tumor Cells Modified with Newcastle Disease Virus Expressing IL-24 as a Cancer Vaccine

Interleukin-24 (IL-24) is a promising agent for cancer immunotherapy that induces apoptosis of tumor cells and enhances T cell activation and function. In order to improve the antitumor activity induced by Newcastle disease virus (NDV)-modified tumor vaccine, we generated a recombinant NDV expressin...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaojing, Yi, Cheng, Yang, Xiaoqin, Xu, Jianwei, Sun, Qing, Liu, Yonghao, Zhao, Lixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630061/
https://www.ncbi.nlm.nih.gov/pubmed/31338417
http://dx.doi.org/10.1016/j.omto.2019.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630061/
https://www.ncbi.nlm.nih.gov/pubmed/31338417
http://dx.doi.org/10.1016/j.omto.2019.06.001

Ejemplares similares